Vaxcyte, Inc. (PCVX) reporting calendar
Vaxcyte, Inc. files periodic reports with the SEC as PCVX on Nasdaq. Atlas tracks 24 filed reports for this issuer, each linked to its original EDGAR accession.
- Next window
- 27 Jul 2026 – 16 Aug 2026
- Latest report
- 10-Q
- Period ended
- 31 Mar 2026
- Filed
- 6 May 2026
- Reports on record
- 24
How this window is derived. Derived from this issuer's own filing history: 9 periods at a median 91-day cadence, filed a median 37 days after period end. The SEC does not publish forward reporting dates and Atlas does not estimate one.
Open PCVX market profile
Latest filing on SEC EDGAR ↗
Biological Products, (No Diagnostic Substances) reporting datesAll Nasdaq reporting dates
Filed periodic reports
| Form | Period ended | Filed | Lag | SEC accession |
|---|---|---|---|---|
| 10-Q | 31 Mar 2026 | 6 May 2026 | 36 days | 0001649094-26-000017 |
| 10-K | 31 Dec 2025 | 24 Feb 2026 | 55 days | 0001649094-26-000007 |
| 10-Q | 30 Sep 2025 | 4 Nov 2025 | 35 days | 0001649094-25-000114 |
| 10-Q | 30 Jun 2025 | 6 Aug 2025 | 37 days | 0001649094-25-000098 |
| 10-Q | 31 Mar 2025 | 7 May 2025 | 37 days | 0001649094-25-000074 |
| 10-K | 31 Dec 2024 | 25 Feb 2025 | 56 days | 0001649094-25-000028 |
| 10-Q | 30 Sep 2024 | 5 Nov 2024 | 36 days | 0001649094-24-000097 |
| 10-Q | 30 Jun 2024 | 6 Aug 2024 | 37 days | 0001649094-24-000052 |
| 10-Q | 31 Mar 2024 | 8 May 2024 | 38 days | 0001628280-24-021677 |
| 10-K | 31 Dec 2023 | 27 Feb 2024 | 58 days | 0000950170-24-021145 |
| 10-Q | 30 Sep 2023 | 6 Nov 2023 | 37 days | 0000950170-23-059395 |
| 10-Q | 30 Jun 2023 | 8 Aug 2023 | 39 days | 0000950170-23-039817 |
| 10-Q | 31 Mar 2023 | 8 May 2023 | 38 days | 0000950170-23-018835 |
| 10-K | 31 Dec 2022 | 27 Feb 2023 | 58 days | 0000950170-23-004654 |
| 10-Q | 30 Sep 2022 | 7 Nov 2022 | 38 days | 0000950170-22-022597 |
| 10-Q | 30 Jun 2022 | 8 Aug 2022 | 39 days | 0000950170-22-015501 |
| 10-Q | 31 Mar 2022 | 9 May 2022 | 39 days | 0000950170-22-008485 |
| 10-K | 31 Dec 2021 | 28 Feb 2022 | 59 days | 0000950170-22-002281 |
| 10-Q | 30 Sep 2021 | 10 Nov 2021 | 41 days | 0001564590-21-056178 |
| 10-Q | 30 Jun 2021 | 11 Aug 2021 | 42 days | 0001564590-21-043419 |
| 10-Q | 31 Mar 2021 | 11 May 2021 | 41 days | 0001564590-21-026529 |
| 10-K | 31 Dec 2020 | 29 Mar 2021 | 88 days | 0001564590-21-016110 |
| 10-Q | 30 Sep 2020 | 12 Nov 2020 | 43 days | 0001564590-20-053540 |
| 10-Q | 30 Jun 2020 | 12 Aug 2020 | 43 days | 0001564590-20-039664 |
Source: SEC EDGAR company submissions for CIK 0001649094. Atlas publishes filed facts only. The SEC does not publish forward reporting dates, so no announced future date is claimed here.